Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016

Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016

Availability, manufacturer and pricing details of generic daclatasvir 60mg in India as on 30th January 2016. Click here for the full list.

/ News

Share the Post

Related Posts

Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Support letter for inclusion of Daclatasvir on 4th March, 2015.
Progress report on access to hepatitis C treatment, WHO March 2018
Part 2: How is hepatitis C treated?
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016